All Comments by Hiroshi Mori

  1. Congo red inhibits proteoglycan and serum amyloid P binding to amyloid beta fibrils.
  2. Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect?
  3. Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease.
  4. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.
  5. Beta-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis.
  6. Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease.
  7. Inhibiting the formation of classical C3-convertase on the Alzheimer's beta-amyloid peptide.
  8. Diffuse plaques in the striatum in Alzheimer disease (AD): relationship to the striatal mosaic and selected neuropeptide markers.
  9. Alzheimer's alpha-secretase may be a calcium-dependent protease.
  10. Melatonin alters the metabolism of the beta-amyloid precursor protein in the neuroendocrine cell line PC12.
  11. Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1.
  12. Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala-->Gly mutation.
  13. Abeta42, presenilins, and Alzheimer's disease.
  14. Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner.
  15. Alpha-2 macroglobulin is genetically associated with Alzheimer disease.